These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18785639)

  • 1. Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy.
    Antonini A; Berto P; Lopatriello S; Tamma F; Annemans L; Chambers M
    Mov Disord; 2008 Nov; 23(15):2202-9. PubMed ID: 18785639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
    Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
    Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
    Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
    Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
    Dodel RC; Höffken H; Möller JC; Bornschein B; Klockgether T; Behr T; Oertel WH; Siebert U
    Mov Disord; 2003 Oct; 18 Suppl 7():S52-62. PubMed ID: 14531047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson's disease by (123)I-FP-CIT brain SPECT.
    Palumbo B; Fravolini ML; Nuvoli S; Spanu A; Paulus KS; Schillaci O; Madeddu G
    Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2146-53. PubMed ID: 20567820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
    Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
    Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
    Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
    Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson's disease.
    Schwartz M; Groshar D; Inzelberg R; Hocherman S
    Parkinsonism Relat Disord; 2004 Aug; 10(6):385-9. PubMed ID: 15261882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
    Marshall VL; Reininger CB; Marquardt M; Patterson J; Hadley DM; Oertel WH; Benamer HT; Kemp P; Burn D; Tolosa E; Kulisevsky J; Cunha L; Costa D; Booij J; Tatsch K; Chaudhuri KR; Ulm G; Pogarell O; Höffken H; Gerstner A; Grosset DG
    Mov Disord; 2009 Mar; 24(4):500-8. PubMed ID: 19117369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I
    Quintas S; Sanles-Falagan R; Berbís MÁ
    Mov Disord Clin Pract; 2024 Jun; 11(6):613-625. PubMed ID: 38693679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
    Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
    Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
    Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
    Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.